Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,510.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 2,525.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 3,526
  • Market Cap: £78.90m

Latest Deals

Traded Action Notifier PriceAmountValue
24-Jun-26 Buy Bruce Hiscock 1,799.00p 534 £9,606.66
27-Apr-26 Buy Bruce Hiscock 1,679.00p 66 £1,108.14
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 306,172 £4,623,197
Ian James Nicholson 14,500 £218,950
Bruce Hiscock 2,200 £33,220

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £78,816,806
Castlefield Fund Partners Limited 985,000 £14,873,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £13,363,500
Gresham House Asset Management Limited 627,782 £9,479,508
Miton Group plc 508,135 £7,672,838
The Diverse Income Trust plc 302,300 £4,564,730
Schroders plc 284,795 £4,300,404
Raymond James Wealth Management Limited 265,453 £4,008,340
Wasatch Advisors, Inc. 265,000 £4,001,500
Premier Miton Group plc 262,812 £3,968,461
Canaccord Genuity Group Inc 259,940 £3,925,094
SANFORD DELAND ASSET MANAGEMENT LTD 254,000 £3,835,400
Adrian Williams 253,372 £3,825,917

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,510.00p
Change Today 10.00p
% Change 0.67 %
52 Week High 2,525.00
52 Week Low 1,366.67
Volume 3,526
Shares Issued 5.22m
Market Cap £78.90m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 07-Aug-2026

Time Volume / Share Price
09:57 27 @ 1,490.73p
09:16 10 @ 1,550.00p
09:16 0 @ 1,550.00p
09:16 0 @ 1,550.00p
09:16 1 @ 1,470.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page